Understanding the Market | AIRDOC-B rose over 12% as AIRDOC's WanYu medical model completed its upgrade and connected to DeepSeek

AIRDOC-B rose over 12%, as of the time of writing, it increased by 11.13%, priced at HKD 12.78, with a transaction volume of HKD 1.4026 million. In terms of news, on February 7th, AIRDOC announced that its self-developed WanYu Medical Large Model has completed a significant upgrade and has integrated the DeepSeek R1 model. It is reported that the company laid out the AIRDOC WanYu Medical Large Model in July 2024 and upgraded to integrate the DeepSeek R1 large model in February 2025, significantly improving clinical diagnosis efficiency and accuracy, providing more professional report interpretations and a more personalized patient health management experience. CITIC Construction Investment pointed out that AIRDOC is the first company in China to obtain the NMPA-approved Class III AI-assisted diagnostic registration certificate. As a leader and pioneer in the global AI retinal image recognition field, the company is committed to using AI research technology to provide integrated AI solutions for chronic disease early screening management and eye health diagnosis and treatment. AIRDOC's main product, Airdoc-AIFUNDUS 1.0, has obtained the first Class III medical device certificate for AI-assisted diagnosis of fundus from the National Medical Products Administration, aimed at assisting in the diagnosis of diabetic retinopathy to help doctors make medical diagnoses